SCHEMBL14176249

SCHEMBL14176249

CCOC(=O)C(C)(Cc1ccccc1)Oc1ccc(O)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARA Q07869 4/20 0.56
▸ PPARG P37231 2/20 0.56
▸ MMP8 P22894 1/20 0.52
▸ OPRK1 P41145 1/20 0.51
▸ ALDH1A1 P00352 2/20 0.49
▸ RECQL P46063 1/20 0.49
▸ CYP1A2 P05177 2/20 0.46
▸ ABCB11 O95342 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ HTR2A P28223 1/20 0.46
▸ PMP22 Q01453 1/20 0.46
▸ LMNA P02545 3/20 0.43
▸ ESR1 P03372 2/20 0.43
▸ ESR2 Q92731 2/20 0.43
▸ CA12 O43570 1/20 0.43
▸ CA1 P00915 1/20 0.43
▸ CA2 P00918 1/20 0.43
▸ CA7 P43166 1/20 0.43
▸ CA9 Q16790 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5116975 0.95 OPRK1 (0.51) PPARAPPARGMMP8OPRK1ALDH1A1
SCHEMBL5118505 0.95 OPRK1 (0.51) PPARAPPARGMMP8OPRK1ALDH1A1
SCHEMBL2804981 0.95 OPRK1 (0.51) PPARAPPARGMMP8OPRK1ALDH1A1
SCHEMBL5213397 0.92 PPARG (0.52) PPARAPPARGMMP8OPRK1ALDH1A1
SCHEMBL14176244 0.90 LMNA (0.54) PPARAPPARGMMP8OPRK1ALDH1A1
SCHEMBL5110581 0.89 OPRK1 (0.54) PPARAPPARGMMP8OPRK1ALDH1A1
SCHEMBL5110571 0.89 OPRK1 (0.54) PPARAPPARGMMP8OPRK1ALDH1A1
SCHEMBL5123296 0.88 OPRK1 (0.53) PPARAPPARGOPRK1ALDH1A1CYP1A2
SCHEMBL5109513 0.88 OPRK1 (0.53) PPARAPPARGOPRK1ALDH1A1CYP1A2
SCHEMBL2807182 0.87 PPARG (0.55) PPARAPPARGMMP8OPRK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080146631-A1 OXAZOLYL-ARYLOXYACETIC ACID DERIVATIVES AND THEIR USE AS PPAR AGONISTS BROOKS DAWN ALISA 2008-06-19 — — US disclosed
US-20080146631-A1 OXAZOLYL-ARYLOXYACETIC ACID DERIVATIVES AND THEIR USE AS PPAR AGONISTS BROOKS DAWN ALISA 2008-06-19 — — US disclosed
US-7351728-B2 Oxazolyl-aryloxyacetic acid derivatives and their use as PPAR agonists ELI LILLY AND COMPANY (US) 2008-04-01 — — US disclosed
US-7351728-B2 Oxazolyl-aryloxyacetic acid derivatives and their use as PPAR agonists ELI LILLY AND COMPANY (US) 2008-04-01 — — US disclosed
EP-1313715-B1 OXAZOLYL-ARYLOXYACETIC ACID DERIVATIVES AND THEIR USE AS PPAR AGONISTS LILLY CO ELI (US) 2007-08-01 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080146631-A1 OXAZOLYL-ARYLOXYACETIC ACID DERIVATIVES AND THEIR USE AS PPAR AGONISTS PPARA, PPARG, PPARD PPARA 1/4885PPARG 2/4885MMP8 3109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback